The results revealed that sotetsuflavone was able to promote the levels of expression of beclin1, Atg5, and Atg7, and induced a decrease in the levels of expression of P62 in A549 non-small cell lung cancer cells (Figure 3). This evidence concerns the gene ATG5 and non-small cell lung carcinoma.